NOE-115 not checked

Noema Pharma AG

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“NOE-115 is an investigational monoamine modulator which has potential anti-inflammatory activity.”In the company’s words, NCT06385795 on ClinicalTrials.gov
Tested for
Menopause Syndrome, Menopause, Hot Flashes
Main trialPhase 2
“The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.”In the company’s words, NCT06385795 on ClinicalTrials.gov

Other drugs for Menopause

All 3 drugs for Menopause

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed 13 Aug 2025 A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow NOE-115

Following is part of Solo: you see every change to NOE-115 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in